Filter
2236
Text search:
clinical
trials
Featured
Recommendations
238
New Publications
381
Language
Document type
No document type
1110
Guidelines
436
Studies & Reports
383
Manuals
113
Fact sheets
80
Strategic & Response Plan
46
Training Material
28
Situation Updates
13
Resource Platforms
12
Infographics
10
Brochures
3
Videos
2
Countries / Regions
India
110
Global
103
South Africa
54
Kenya
36
Western and Central Europe
36
Africa
29
Uganda
24
Sierra Leone
22
Ethiopia
22
Zambia
21
East and Southern Africa
21
Nigeria
20
West and Central Africa
20
Latin America and the Carribbean
19
Liberia
18
Brazil
18
Malawi
17
Russia
17
Nepal
16
Tanzania
16
Eastern Europe
16
Ghana
15
Philippines
15
Rwanda
15
Ukraine
15
Zimbabwe
14
Indonesia
12
Germany
11
Bangladesh
11
Namibia
11
South–East Asia Region
11
Congo, Democratic Republic of
10
Mozambique
10
Asia
10
Guinea
9
Middle East and North Africa
9
South Sudan
8
Cameroon
7
USA
6
Cambodia
6
Peru
6
Eswatini/ Swaziland
6
Lesotho
6
Thailand
5
Colombia
5
Botswana
5
Angola
5
Eastern Europe and Central Asia
5
Albania
5
Burkina Faso
4
Senegal
4
China
4
Vietnam
4
North America
4
United Kingdom
4
Mali
3
Guinea-Bissau
3
Haiti
3
Sudan
3
Argentina
3
Myanmar / Burma
3
Chile
3
Laos
3
France
3
Spain
3
Côte d’Ivoire / Ivory Coast
2
Pakistan
2
Iraq
2
Lebanon
2
Syria
2
Chad
2
Burundi
2
Sri Lanka
2
Tajikistan
2
Estonia
2
Georgia
2
Morocco
1
Saudi Arabia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Ireland
1
Singapore
1
Benin
1
Ecuador
1
Greece
1
Madagascar
1
Paraguay
1
Canada
1
Bulgaria
1
Moldova
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Denmark
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
533
Clinical Guidelines
325
Public Health
143
Women & Child Health
130
Key Resources
40
Pharmacy & Technologies
32
Capacity Building
22
Toolboxes
Mental Health
290
COVID-19
266
HIV
243
TB
183
NTDs
109
NCDs
89
AMR
67
Ebola & Marburg
61
Pharmacy
51
Caregiver
50
Malaria
45
Rapid Response
29
Disability
27
Planetary Health
24
Global Health Education
19
Refugee
18
Polio
13
Health Financing Toolbox
12
2.0 Rapid Response
12
Conflict
11
Zika
11
Cholera
10
Natural Hazards
4
Social Ethics
3
Specific Hazards
2
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in the clin
...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin
...
This document provides technical guidance for manufacturers seeking World Health Organization (WHO) prequalification of in vitro diagnostic devices (IVDs) for malaria, with a focus on rapid diagnostic tests (RDTs) for symptomatic patients. It summarises the minimum performance requirements, includin
...
The recommendations in this guideline are intended to inform the development of relevant national- and local-level health policies and clinical protocols. Therefore, the target audience includes national and local public health policy-makers, implem
...
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc
...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent C
...
Patients with diabetes are at increased risk of developing cardiovascular disease (CVD) with its manifestations of coronary artery disease (CAD), heart failure (HF), atrial fibrillation (AF), and stroke, as well as aortic and peripheral artery diseases. In addition, diabetes is a major risk factor f
...
The recommendations in this guideline are intended to inform development of national and subnational health policies, clinical protocols and programmatic guides. The target audience includes national and subnational public health policy-makers, impl
...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently
...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w
...
Prepared as an outcome of ICMR Subcommittee on Esophageal Cancer | This consensus document on management of esophageal cancers
summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It a
...
A practical manual - The book provides step by step guidance
to the process of rational prescribing, together with many illustrative examples. It teaches skills that are necessary throughout a clinical career.
This document focuses on making recommendations for the diagnosis and treatment of Chagas disease, an infection caused by Trypanosoma cruzi, the protozoan agent of a systemic parasitic disease. Methodology: These clinical practice guidelines were pr
...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t
...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are
...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines
...
Prepared as an outcome of ICMR Subcommittee on Multiple Myeloma | This consensus document on management of multiple myeloma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also i
...
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guideli
...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca
...
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interwe
...
